Distinct Effects of Saracatinib on Memory CD8+ T Cell Differentiation

The Journal of Immunology, 05/09/2012

Vaccine plus saracatinib treatment showed better protection against tumor challenge. The immune–potentiating effects on CD8+ T cells by a low dose of saracatinib might afford better protection from pathogens or cancer when combined with vaccine.

Print Article Summary Cat 2 CME Report